The 71st Annual Meeting of the Japan Society of Human Genetics

Aya Kawasaki¹, Ken-ei Sada^2,3, Kenji Itoh⁴, Nobuyuki Ono⁵, Fumio Hirano⁶, Shigeto Kobayashi⁷, Kenji Nagasaka⁸, Takahiko Sugihara⁹, Takashi Fujimoto¹⁰, Makio Kusaoi¹¹, Takashi Higuchi^1,12, Hajime Kono¹³, Kunihiro Yamagata¹⁴, Hiroshi Hashimoto¹⁵, Hirofumi Makino¹⁶, Yoshihiro Arimura^17,18, Naoto Tamura¹¹, Masayoshi Harigai¹⁹, Naoyuki Tsuchiya¹ (1. Molecular and Genetic Epidemiology, University of Tsukuba, Tsukuba, Japan, 2. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Okayama, Japan, 3. Department of Clinical Epidemiology, Kochi University, Kochi, Japan, 4. Division of Hematology and Rheumatology, National Defense Medical College, Tokorozawa, Japan, 5. Department of Rheumatology, Faculty of Medicine, Saga University, Saga, Japan, 6. Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, 7. Department of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan, 8. Department of Rheumatology, Ome Medical Center, Ome, Japan, 9. Department of Rheumatology, Institute of Science Tokyo, Tokyo, Japan, 10. Department of General Medicine, Nara Medical University, Nara, Japan, 11. Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan, 12. Department of Nephrology, Ushiku Aiwa General Hospital, Ushiku, Japan, 13. Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 14. Department of Nephrology, University of Tsukuba, Tsukuba, Japan, 15. School of Medicine, Juntendo University, Tokyo, Japan, 16. Okayama University, Okayama, Japan, 17. Department of Nephrology and Rheumatology, Kyorin University, Tokyo, Japan, 18. Department of Internal Medicine, Kichijoji Asahi Hospital, Tokyo, Japan, 19. Department of Rheumatology, International University of Health and Welfare School of Medicine, Chiba, Japan)

Haruka Naoe¹, Tomoyasu Matsubara², Kenta Hanada³, Masaki Kamada⁴, Kazuki Sogawa³, Miki Tani³, Ryosuke Miyamoto³, Koji Fujita⁵, Yuishin Izumi⁵, Hiroyuki Morino¹ (1. Department of Medical Genetics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 2. Department of Neurology, Hiroshima University Hospital, Hiroshima, Japan, 3. Department of Neurology, Tokushima University Hospital, Tokushima, Japan, 4. Department of Neurology, Kagawa University Hospital, Kagawa, Japan, 5. Department of Clinical Neuroscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan)

Daisuke Nishizawa^1,2, Takeshi Terui³, Kunihiko Ishitani³, Shinya Kasai², Junko Hasegawa², Kyoko Nakayama^1,2, Kazutaka Ikeda^1,2 (1. Department of Neuropsychopharmacology, National Institute of Mental Health, National Institute of Neurology and Psychiatry, Tokyo, Japan, 2. Department of Clinical Medical Sciences (Addictive Substance Project), Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 3. Division of Internal Medicine, Department of Medicine, Higashi-Sapporo Hospital, Hokkaido, Japan)